Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.
Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.
HSBC Holdings PLC said Monday that its subsidiary has gained approval to take Hang Seng Bank Ltd. of Hong Kong private in an all-cash deal valued at 106 billion Hong Kong dollars ($13.6 billion), setting the stage for a vote in early 2026.
DBay Advisors Ltd., a significant shareholder in TT Electronics PLC, said Monday that it will not table a takeover offer for the British engineering group, ending speculation over a rival bid in an ongoing acquisition battle.
Healthcare investor HBM said Monday that it has agreed to sell a majority stake in Swixx Biopharma to U.S.-based investor SK Capital Partners LP in a deal that values the Swiss company at €1.5 billion ($1.76 billion).
Intuitive Investments said Monday that British investment manager Helikon Investments has agreed to invest up to £30 million ($40.1 million) in Hui10 – the company's business focused on digitizing the lottery in China.
Sports Direct owner Frasers Group PLC said Monday that it will return up to £70 million ($93.7 million) to its shareholders in a share buyback program that will last until April 24.
Broadfield Law has hit back against a £10 million ($13.4 million) negligence claim over a botched property transaction, arguing it cannot be held liable for the actions of its predecessor.
Simmons & Simmons LLP said Monday that it has hired a U.S. securities law expert from UBS Investment Bank to enhance its services in equity capital markets transactions.
The proliferation of U.K. and European Union sanctions targeting Russia has led to a vast increase in legislative provisions, and lawyers advising affected businesses should expect a complex and evolving legal landscape for the foreseeable future, says Rob Dalling at Jenner & Block.
